Last update Jan. 2, 2022
Very Low Risk
It is a non-steroidal anti-inflammatory drug (NSAID). Indicated in joint and musculoskeletal pain, osteoarthritis and rheumatoid arthritis. Oral administration in three daily doses.
It is excreted in breast milk in clinically insignificant amounts.(Sagraves 1985)
American Academy of Pediatrics: medication usually compatible with breastfeeding. (AAP 2001)
Until more published data is known about this drug in relation to breastfeeding, known safer alternatives may be preferable, especially during the neonatal period and in the event of prematurity.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM